Philip Morris International Aspires to Become a Tech Company Comparable to Tesla.

Market
Sep.29.2022
Deepak Mishra's presentation was on "PMI's Nicotine Harm Reduction and Tobacco Free Transition".

The 2022 Global Tobacco and Nicotine Forum (GTNF) was inaugurated on September 28, at 9:00 EST, at the Four Seasons Hotel in Washington, D.C. (21:00 BST).

 

Deepak Mishra, president of PMI's Americas region, delivered the first keynote talk of the summit, titled "PMI's Nicotine Harm Reduction and Tobacco-Free Transformation," following the opening remarks.

 

Philip Morris International Aspires to Become a Tech Company Comparable to Tesla.

Deepak on his Keynote

Deepak Mishra stated, "It is a cruel reality that the majority of PMI's earnings come from traditional tobacco, and as the industry consumes less and less, this will become an important factor for PMI to transition to a smoke-free environment."

 

Deepak Mishra articulated four to five key points for PMI smoke-free transition, including the industry must be self-regulatory, the market must provide sufficient incentive for more traditional tobacco users to switch to e-cigarettes (along with nicotine harm reduction), and product innovation must reduce combustible cigarette products as much as possible.

 

Innovation is the most significant factor in achieving this objective. To this aim, Deepak Mishra drew a parallel between the tobacco industry and the automotive industry, stating, "Both the automotive sector and the tobacco industry can make progress in decreasing emissions by 2022." In the future PMI will become a technology firm similar to Tesla, rather than a traditional cigarette corporation. Meanwhile, PMI will collaborate with additional physicians to perform research on nicotine harm reduction in the future.

*This article is an original article of 2FIRSTS Technology Co., Ltd. The copyright and license rights belong to the company. Any entity or individual shall make link and credit 2FIRSTS when taking actions to copy, reprint or distribute the original article. The company retains the right to pursue its legal responsibility.

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”
At a policy forum hosted by The Hill and sponsored by PMI US, U.S. defense health officials, lawmakers and industry representatives discussed tobacco use in the military and explored the potential role of smoke-free nicotine products — including e-cigarettes and nicotine pouches — as transitional tools to help service members reduce reliance on combustible cigarettes.
PMI
Mar.23
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13